Abstract
A recent study found that approximately 1 in every 6 patients hospitalized for the 1st episode of syncope had an underlying pulmonary embolism (PE). As current guidelines do not strongly emphasize evaluation for PE in the workup of syncope, we hypothesize that there might be a higher rate of 30-day readmission due to untreated venous thromboembolism (VTE). The objective of this study is to measure the 30-day readmission rate due to VTE and identify predictors of 30-day readmission with VTE among syncope patients. We identified patients admitted with syncope with ICD9 diagnoses code 780.2 in the Nationwide Readmission Database (NRD-2013), Healthcare Cost and Utilization Project (HCUP). The 30-day readmission rate was calculated using methods described by HCUP. Logistic-regression was used to identify predictors of 30-day readmission with VTE. Discharge weights provided by HCUP were used to generate national estimates. In 2013, NRD included 207,339 eligible patients admitted with syncope. The prevalence rates of PE and DVT were 1.1% and 1.4%, respectively. At least one syncope associated condition was present in 60.9% of the patients. Among the patients who were not diagnosed with VTE during index admission for syncope (N = 188,015), 30-day readmission rate with VTE was 0.5% (0.2% with PE and 0.4% with DVT). In conclusion, low prevalence of VTE in patients with syncope and extremely low 30-day readmission rate with VTE argues against missed diagnoses of VTE in index admission for syncope. These results warrant further studies to determine clinical impact of work up for PE in syncope patients without risk factors.
Introduction
Syncope refers to transient loss of consciousness that is characterized by rapid onset, short duration (few seconds), and spontaneous resolution. It is related to temporary cerebral hypoperfusion. Syncope is an atypical presentation of acute pulmonary embolism (PE). It is usually seen in association with central and/or massive PE [1–3]. The occlusion of >50% of pulmonary vascular bed can result in acute right ventricular failure followed by impaired left ventricular filling, diminished cardiac output, hypotension, and cerebral hypoperfusion [1]. However, the occurrence of syncope in the setting of non-massive PE may be explained by other pathophysiology such as hemodynamically unstable dysrhythmia and vasovagal reflex [4]. Recently published report found that approximately one of every six patients (17.3%) hospitalized for the first episode of syncope had underlying PE [5]. As current international guidelines do not strongly emphasize on evaluation for PE in the work up of syncope [6–8], it is possible that several syncope patients with undiagnosed PE could have been discharged from the hospital without any treatment for their PE. Hence, we hypothesize that syncope patients discharged without diagnoses of venous thromboembolism (VTE) could have high 30-day readmission rates due to untreated VTE. The objective of this study is to measure 30-day readmission rate due to VTE and identify predictors of 30-day readmission with VTE among syncope patients.
Materials and methods
We identified patients admitted with syncope with ICD9 diagnoses code 780.2 in the Nationwide Readmission Database (NRD-2013), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality [9]. Patients with PE were identified by ICD9 diagnoses code 415.1[10]. Patients below18 years of age, pregnant patients, patients on anticoagulants and patients with elective 30 day readmission were excluded. Other syncope associated conditions were identified by ICD-9 codes. All the ICD-9 Codes used in analysis are provided in S1 Table. Deyo’s modification of Charlson’s Co-morbidity Index (CCI) was used to quantify severity of co-morbid conditions [11]. The primary outcome was 30 day unplanned readmission rate with VTE, including PE and deep vein thrombosis (DVT) in syncope patients discharged without diagnoses of VTE during index hospitalization. The 30 day readmission rate was calculated using methods described by HCUP[12]. Logistic regression was used to identify predictors of 30 day readmission with VTE. Discharge weights provided by HCUP were used to generate national estimates. Using SAS 9.3, SURVEY procedures with WEIGHT, STRATA, and CLUSTER statements were used to adjust for stratified cluster design of NRD. We accessed and analyzed these data in compliance with the Health Insurance Portability and Accountability Act of 1996, so this protocol is exempted from the institutional review board’s approval at University of Pittsburgh Medical Center. A flow chart on study design is provided in S1 Fig.
Results
In 2013, NRD included 207,339 eligible patients admitted with syncope. The prevalence rates of PE and DVT were 1.1% and 1.4%, respectively. At least one syncope associated condition was present in 60.9% of the patients. 39.1% of patients had no apparent cause of syncope upon discharge.
Among the patients who were not diagnosed with VTE during index admission for syncope (N = 188,015), 30 day readmission rate with VTE was 0.5% (0.2% with PE and 0.4% with DVT). Among the patients diagnosed with or without syncope associated conditions on index admission, 30 day readmission rate with VTE was 0.6% and 0.4%, respectively. The differences in the baseline characteristics of syncope patients with and without 30 day readmission with VTE are shown in Table 1. A higher proportion of patients with 30 day readmission with VTE were males (52.2% vs. 46.8%, p = 0.004). Patients with 30 day readmission with VTE had higher burden of co-morbid conditions (CCI 2.34 vs. 1.51, p<0.0001) compared to patients without 30 day readmission with VTE; including higher age, obesity, heart and/or respiratory failure, rheumatologic disorder and/or acute infection, active cancer, decreased mobility and recent trauma or surgery (Table 1). The patients with 30 day readmission with VTE had a higher length of stay in index admission (5.58 days vs 3.82 days, p<0.0001) and higher rates of discharge with home health care (22.1% vs. 14.33%, p<0.0001) or discharge to facility (27.3% vs. 16.9%, p<0.0001) compared to patients without 30 day readmission with VTE.
Table 1. Baseline characteristics of 30-day readmissions in syncope patients with Venous Thromboembolism (VTE) (N = 188,015).
| Characteristics | Syncope with VTE patients with 30 day readmission (N = 919) | Syncope with VTE patients without 30 day readmission (N = 187,096) | P-value |
|---|---|---|---|
| Gender (%) | 0.0044 | ||
| Male | 52.15 | 46.75 | |
| Female | 47.85 | 53.26 | |
| Charlson/Deyo comorbidity index (mean ± SE) | 2.34±0.09 | 1.51± 0.01 | < .0001 |
| Comorbidities (%) | |||
| Age ≥ 70 years | 56.88 | 52.66 | 0.0417 |
| Obesity | 11.99 | 9.38 | 0.0139 |
| Hormonal Therapy | 0.08 | 0.06 | 0.84 |
| Heart and/or respiratory failure | 23.85 | 16.29 | < .0001 |
| Ischemic stroke or acute myocardial infarction | 13.43 | 11.12 | 0.055 |
| Acute rheumatologic disorder and/or acute infection | 40.67 | 33.11 | < .0001 |
| Active cancer | 15.75 | 5.00 | < .0001 |
| Previous VTE | 10.46 | 2.57 | < .0001 |
| Decreased mobility | 3.07 | 1.98 | 0.0399 |
| History of Thrombophilia | 0.55 | 2.00 | 0.066 |
| Previous trauma /surgery within last month | 28.95 | 20.76 | < .0001 |
| Median household income category for patient's zip code (percentile) | 0.93 | ||
| 0-25th | 28.72 | 29.48 | |
| 26-50th | 26.06 | 26.16 | |
| 51-75th | 24.34 | 23.22 | |
| 76-100th | 20.88 | 21.14 | |
| Primary Payer (%) | 0.0004 | ||
| Medicare | 70.97 | 64.53 | |
| Medicaid | 8.65 | 8.39 | |
| Private including HMO | 14.75 | 18.89 | |
| Self-pay/no charge/other | 5.64 | 8.19 | |
| Hospital characteristics (%) | |||
| Hospital bed size | 0.0069 | ||
| Small | 9.48 | 12.10 | |
| Medium | 22.14 | 25.03 | |
| Large | 68.38 | 62.87 | |
| Hospital location/teaching status (%) | 0.0005 | ||
| Metropolitan non-teaching | 40.62 | 40.77 | |
| Metropolitan teaching | 52.62 | 48.06 | |
| Non-metropolitan hospital | 6.76 | 11.17 | |
| Admission type (%) | 0.20 | ||
| Non-Elective | 93.05 | 94.13 | |
| Elective | 6.95 | 5.87 | |
| Admission day (%) | 0.74 | ||
| Weekday | 75.04 | 74.49 | |
| Weekend | 24.96 | 25.51 | |
| Length of stay (Means ± SE) | 5.58±0.20 | 3.82±0.03 | < .0001 |
| Disposition (%) | < .0001 | ||
| Home | 49.49 | 66.75 | |
| Home health care | 22.09 | 14.33 | |
| Facility | 27.34 | 16.94 | |
| Against medical advice | 1.08 | 1.99 | |
# Values are numbers (percentages) unless otherwise indicated.
Multivariable predictors of 30-day readmissions with VTE in syncope patients are listed in Table 2. Factors associated with higher 30-day readmissions with VTE included history of previous VTE (OR: 3.74; p<0.0001), active cancer (OR: 3.08; p<0.0001), obesity (OR: 1.29; p = 0.025), trauma or surgery in last 1 month (OR: 1.32; p = 0.002), respiratory and/or heart failure (OR: 1.29; p = 0.004), acute rheumatologic disorder and/or acute infection (OR: 1.18; p = 0.036), large bed size hospital (OR: 1.35, p = 0.006), discharge to facility (OR: 1.94, p<0.0001), and home health care (OR: 1.78, p = 0.001). Factors associated with lower 30-day readmissions with VTE included female sex (OR: 0.78, p = 0.002) and non-metropolitan hospital (OR: 0.62, p = 0.002). Traditional risk factors such as age above 70 years, history of thrombophilia, or hormonal therapy use did not appear to increase the risk of 30-day readmission for VTE.
Table 2. Multivariate predictors of 30-days unplanned readmission with Venous thromboembolism in syncope patients (N = 188,015, weighted N = 419,276).
| Predictors | Odds Ratio (95% Confidence Interval) | P-value# |
|---|---|---|
| Age ≥ 70 years | 0.89 (0.72–1.10) | 0.27 |
| Male | Ref | |
| Female | 0.78 (0.67–0.91) | 0.002 |
| Hospital type | ||
| Metropolitan non-teaching hospital | Ref | |
| Metropolitan teaching hospital | 1.03 (0.89–1.20) | 0.69 |
| Non-metropolitan hospital | 0.62 (0.46–0.85) | 0.002 |
| Hospital bed size | ||
| Small | Ref | |
| Medium | 1.13 (0.84–1.51) | 0.78 |
| Large® | 1.35 (1.04–1.75) | 0.006 |
| Discharge type | ||
| Routine | Ref | |
| Discharge to short term hospital, SNF*, ICF* | 1.94 (1.59–2.38) | < .0001 |
| Home health care | 1.78 (1.44–2.19) | 0.001 |
| Against medical advice | 0.69 (0.37–1.28) | 0.23 |
| Hospital zip code income quartile (In percentile) | ||
| 0-25th | Ref | |
| 26-50th | 1.00 (0.81–1.24) | 0.93 |
| 51-75th | 1.03 (0.80–1.32) | 0.66 |
| 76-100thβ | 0.95 (0.76–1.18) | 0.47 |
| Admission type | ||
| Elective | 1.07 (0.80–1.43) | 0.64 |
| Weekend | 0.99 (0.83–1.19) | 0.95 |
| Comorbidities | ||
| Obesity | 1.29 (1.03–1.61) | 0.025 |
| Heart and/or respiratory failure | 1.29 (1.08–1.53) | 0.004 |
| Acute rheumatologic disorder and/or acute infection | 1.18 (1.01–1.37) | 0.036 |
| Previous trauma or surgery within that last month | 1.32 (1.10–1.57) | 0.002 |
| Active cancer | 3.08 (2.48–3.84) | < .0001 |
| Previous history of VTE | 3.74 (2.94–4.76) | < .0001 |
| Hormonal therapy | 1.62 (0.22–12.03) | 0.64 |
| Ischemic stroke or acute myocardial infarction | 1.10 (0.88–1.37) | 0.41 |
| Decreased mobility | 1.18 (0.76–1.86) | 0.46 |
| History of thrombophilia | 1.49 (0.48–4.61) | 0.49 |
*SNF = Skilled nursing facility; ICF = Intermediate care facility
β Median household income for patient's ZIP Code
® Bedsize of hospital-derived from https://www.hcup-us.ahrq.gov/db/vars/hosp_bedsize/nrdnote.jsp
# P value at 95% confidence interval.
Discussion
Our study has demonstrated that the prevalence of PE is low in patients presenting with syncope using a large nationwide database compared to the recently published report [5] and similar to other studies[13, 14]. Our study also showed that a majority of patients had at least one syncope associated diagnosis at index admission, and one should consider PE as an etiology if syncope is unexplained[15]. More recently, Costantino et al. have shown a similar low prevalence rate of PE of less than 3% in hospitalized patients and less than 1% within 90 days of follow-up [16]. Moreover, the 30 day readmission rate with VTE was also significantly low in patients with and without syncope associated diagnoses during the index admission. Another study by Epstein et al. have shown that at 3 year follow up in anticoagulant naïve patients, the cumulative incidence of VTE was low at 1.9%, indicating that PE is an uncommon cause of syncope [17]. Since NRD does not capture death outside the hospital, it is possible that a certain number of patients may have died after discharge due to untreated PE. However, extremely low readmission rates due to VTE argue against missed diagnoses of clinically significant PE during their index admission. PE is an uncommon cause of syncope and would need a high index of clinical suspicion before considering appropriate work up[6, 18]. These results warrant a prospective investigation regarding relevant workup for PE in patients admitted for syncope, which might include using pretest probability score like PERC Rule or Wells Criteria, appropriate use of D-dimer testing and considering further imaging based on the results [19–21]. It might be more reasonable to consider VTE work up in syncope patients with hemodynamic instability [15, 22].
The syncope patients with other risk factors for VTE (history of previous VTE, active cancer, obesity, trauma or surgery in last 1 month, respiratory and/or heart failure, and acute rheumatologic disorder and/or acute infection) are at higher risk for 30 day readmission with VTE. This may indicate that among these patients, diagnoses of VTE may have been missed during the index admission for syncope. Hence, a higher index of suspicion for VTE is necessary for patients presenting with syncope that has these risk factors.
Our study has several limitations. The NRD does not contain patient identifiers, and it is not possible to confirm the listed diagnoses. Since the NRD does not contain data on vital signs, laboratory values, radiological data, EKG, or specific medications, we are unable to assess the severity of VTE. We are unable to capture patients with VTE who are treated as an outpatient after discharge. However, given the large sample size, we believe that the estimates of the prevalence of VTE in syncope patients, 30-day readmission rate with VTE, and predictors of 30 day readmission with VTE are reliable.
In conclusion, the prevalence of diagnosed VTE is low in patients with syncope. An extremely low 30 day readmission rate with VTE argues against missed diagnoses of VTE. A higher index of suspicion for VTE is necessary for patients presenting with syncope that has specific risk factors for VTE.
Supporting information
(TIFF)
(DOCX)
Data Availability
National readmission data (NRD) is available from the Healthcare Cost and Utilization Project (HCUP) to all researchers following a standard application process and signing of a data usage agreement. Future researchers need to complete the necessary modules and pay required fees to access the data (https://www.hcup-us.ahrq.gov/db/nation/nrd/nrddbdocumentation.jsp).
Funding Statement
The authors received no specific funding for this work.
References
- 1.Thames MD, Alpert JS, Dalen JE. Syncope in patients with pulmonary embolism. Jama. 1977;238(23):2509–11. Epub 1977/12/05. . [PubMed] [Google Scholar]
- 2.Morpurgo M, Zonzin P. Syncope in acute pulmonary embolism. Ital Heart J. 2004;5(1):3–5. Epub 2004/04/15. . [PubMed] [Google Scholar]
- 3.Jenab Y, Lotfi-Tokaldany M, Alemzadeh-Ansari MJ, Seyyedi SR, Shirani S, Soudaee M, et al. Correlates of syncope in patients with acute pulmonary thromboembolism. Clin Appl Thromb Hemost. 2015;21(8):772–6. Epub 2014/07/06. 10.1177/1076029614540037 . [DOI] [PubMed] [Google Scholar]
- 4.Altinsoy B, Erboy F, Tanriverdi H, Uygur F, Ornek T, Atalay F, et al. Syncope as a presentation of acute pulmonary embolism. Ther Clin Risk Manag. 2016;12:1023–8. Epub 2016/07/09. 10.2147/TCRM.S105722 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Prandoni P, Lensing AW, Prins MH, Ciammaichella M, Perlati M, Mumoli N, et al. Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope. The New England journal of medicine. 2016;375(16):1524–31. Epub 2016/11/01. 10.1056/NEJMoa1602172 . [DOI] [PubMed] [Google Scholar]
- 6.Shen WK, Sheldon RS, Benditt DG, Cohen MI, Forman DE, Goldberger ZD, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2017;14(8):e155–e217. Epub 2017/03/14. 10.1016/j.hrthm.2017.03.004 . [DOI] [PubMed] [Google Scholar]
- 7.Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30(21):2631–71. Epub 2009/08/29. 10.1093/eurheartj/ehp298 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Konstantinides SV, Meyer G. The 2019 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism. Eur Heart J. 2019;40(42):3453–5. Epub 2019/11/08. 10.1093/eurheartj/ehz726 . [DOI] [PubMed] [Google Scholar]
- 9.HCUP National Readmission Database (NRD). Healthcare Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality; 2013. [Google Scholar]
- 10.Mehta KD, Siddappa Malleshappa SK, Patel S, Giri S, Wang H, Smith R, et al. Trends of Inpatient Venous Thromboembolism in United States Before and After the Surgeon General's Call to Action. Am J Cardiol. 2019. Epub 2019/07/22. 10.1016/j.amjcard.2019.06.015 . [DOI] [PubMed] [Google Scholar]
- 11.Roffman CE, Buchanan J, Allison GT. Charlson Comorbidities Index. Journal of physiotherapy. 2016;62(3):171 Epub 2016/06/15. 10.1016/j.jphys.2016.05.008 . [DOI] [PubMed] [Google Scholar]
- 12.Barrett M RS AR. Overview of Key Readmission Measures and Methods HCUP Methods Series Report #2012–04: U.S. Agency for Healthcare Research and Quality. 2012.
- 13.Frizell A, Fogel N, Steenblik J, Carlson M, Bledsoe J, Madsen T. Prevalence of pulmonary embolism in patients presenting to the emergency department with syncope. Am J Emerg Med. 2018;36(2):253–6. Epub 2017/08/16. 10.1016/j.ajem.2017.07.090 . [DOI] [PubMed] [Google Scholar]
- 14.Kelly C, Bledsoe JR, Woller SC, Stevens SM, Jacobs JR, Butler AM, et al. Diagnostic yield of pulmonary embolism testing in patients presenting to the emergency department with syncope. Res Pract Thromb Haemost. 2020;4(2):263–8. Epub 2020/02/29. 10.1002/rth2.12294 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Pop C, Ianos R, Matei C, Mercea D, Todea B, Dicu D, et al. Prospective Study of Pulmonary Embolism Presenting as Syncope. Am J Ther. 2019;26(3):e301–e7. Epub 2019/05/15. 10.1097/MJT.0000000000000825 . [DOI] [PubMed] [Google Scholar]
- 16.Costantino G, Ruwald MH, Quinn J, Camargo CA Jr., Dalgaard F, Gislason G, et al. Prevalence of Pulmonary Embolism in Patients With Syncope. JAMA Intern Med. 2018;178(3):356–62. Epub 2018/01/31. 10.1001/jamainternmed.2017.8175 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Epstein D, Berger G, Barda N, Marcusohn E, Barak-Corren Y, Muhsen K, et al. The incidence of acute pulmonary embolism following syncope in anticoagulant-naive patients: A retrospective cohort study. PLoS One. 2018;13(3):e0193725 Epub 2018/03/08. 10.1371/journal.pone.0193725 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Badertscher P, du Fay de Lavallaz J, Hammerer-Lercher A, Nestelberger T, Zimmermann T, Geiger M, et al. Prevalence of Pulmonary Embolism in Patients With Syncope. J Am Coll Cardiol. 2019;74(6):744–54. Epub 2019/08/10. 10.1016/j.jacc.2019.06.020 . [DOI] [PubMed] [Google Scholar]
- 19.Kline JA, Mitchell AM, Kabrhel C, Richman PB, Courtney DM. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost. 2004;2(8):1247–55. Epub 2004/08/12. 10.1111/j.1538-7836.2004.00790.x . [DOI] [PubMed] [Google Scholar]
- 20.Wells PS, Anderson DR, Rodger M, Stiell I, Dreyer JF, Barnes D, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Annals of internal medicine. 2001;135(2):98–107. Epub 2001/07/17. 10.7326/0003-4819-135-2-200107170-00010 . [DOI] [PubMed] [Google Scholar]
- 21.Kearon C, de Wit K, Parpia S, Schulman S, Afilalo M, Hirsch A, et al. Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability. The New England journal of medicine. 2019;381(22):2125–34. Epub 2019/11/28. 10.1056/NEJMoa1909159 . [DOI] [PubMed] [Google Scholar]
- 22.Barco S, Ende-Verhaar YM, Becattini C, Jimenez D, Lankeit M, Huisman MV, et al. Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2018;39(47):4186–95. Epub 2018/10/20. 10.1093/eurheartj/ehy631 . [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
(TIFF)
(DOCX)
Data Availability Statement
National readmission data (NRD) is available from the Healthcare Cost and Utilization Project (HCUP) to all researchers following a standard application process and signing of a data usage agreement. Future researchers need to complete the necessary modules and pay required fees to access the data (https://www.hcup-us.ahrq.gov/db/nation/nrd/nrddbdocumentation.jsp).